Skip to main content

Table 3 Reviewer responses during Phase 1 of external validation study

From: Analytical validation of Exandra: a clinical decision support system for promoting guideline-directed therapy of type-2 diabetes in primary care – a collaborative study with experts from Diabetes Canada

Response

Total (N = 1000)

Chapter 1. Glycemic management (n = 297)

Chapter 2. Dyslipidemia (n = 297)

Chapter 3. Blood pressure control (n = 297)

Chapter 4. Anti-platelet therapy (n = 109)

PP

 Yes

556

151

179

144

82

 No

259

92

70

92

5

 Not sure

135

39

33

46

17

PN

 Yes

6

1

2

1

2

 No

35

11

11

11

2

 Not sure

9

3

2

3

1

  1. PN predicted negative, PP predicted positive